{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:03:33Z","timestamp":1784765013198,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cld.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:37:09Z","timestamp":1780313829000},"page":"775-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perihilar Cholangiocarcinoma in Primary Sclerosing Cholangitis"],"prefix":"10.1016","volume":"30","author":[{"given":"Asim","family":"Abdulhamid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Heimbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2026.04.011_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.04.011_bib2","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","article-title":"AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma","volume":"77","author":"Bowlus","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib4","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.cgh.2024.09.037","article-title":"Incidence of hepatobiliary malignancies in primary sclerosing cholangitis: systematic review and meta-analysis","volume":"23","author":"Souza","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.04.011_bib5","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1053\/j.gastro.2017.02.038","article-title":"Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis","volume":"152","author":"Weismuller","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2026.04.011_bib6","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2026.04.011_bib7","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jgh.13774","article-title":"Variations in primary sclerosing cholangitis across the age spectrum","volume":"32","author":"Eaton","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.04.011_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ajg.2016.55","article-title":"Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD","volume":"111","author":"Gulamhusein","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.011_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.011_bib10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.011_bib11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jgh.13263","article-title":"Performance of magnetic resonance elastography in primary sclerosing cholangitis","volume":"31","author":"Eaton","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.04.011_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2796.2001.00775.x","article-title":"Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma","volume":"249","author":"Bergquist","year":"2001","journal-title":"J Intern Med"},{"key":"10.1016\/j.cld.2026.04.011_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.cld.2026.04.011_bib14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12885-019-5391-0","article-title":"Molecular pathogenesis of cholangiocarcinoma","volume":"19","author":"Labib","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cld.2026.04.011_bib15","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Ilyas","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2026.04.011_bib16","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1053\/j.gastro.2015.08.046","article-title":"An optimized set of fluorescence in situ hybridization probes for detection of pancreatobiliary tract cancer in cytology brush samples","volume":"149","author":"Barr Fritcher","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2026.04.011_bib17","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/hep.31575","article-title":"Early cholangiocarcinoma detection with magnetic resonance imaging versus ultrasound in primary sclerosing cholangitis","volume":"73","author":"Eaton","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib18","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2026.04.011_bib19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2026.04.011_bib20","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2013.08.005","article-title":"FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"59","author":"Wannhoff","year":"2013","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2026.04.011_bib21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/cncy.21331","article-title":"Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy","volume":"121","author":"Barr Fritcher","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.cld.2026.04.011_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib23","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ejso.2005.05.012","article-title":"Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture","volume":"31","author":"Wakabayashi","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.cld.2026.04.011_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00330-021-08147-7","article-title":"Reporting standards for primary sclerosing cholangitis using MRI and MR cholangiopancreatography: guidelines from MR Working Group of the International Primary Sclerosing Cholangitis Study Group","volume":"32","author":"Venkatesh","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cld.2026.04.011_bib25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.29293","article-title":"Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group","volume":"66","author":"Schramm","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11901-017-0341-2","article-title":"Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma?","volume":"16","author":"Chapman","year":"2017","journal-title":"Curr Hepat Rep"},{"issue":"5","key":"10.1016\/j.cld.2026.04.011_bib27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.gie.2013.09.015","article-title":"Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"79","author":"Trikudanathan","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2026.04.011_bib28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(00)70435-4","article-title":"Triple-tissue sampling at ERCP in malignant biliary obstruction","volume":"51","author":"Jailwala","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2026.04.011_bib29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.1840120421","article-title":"Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures","volume":"12","author":"Rabinovitz","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ajg.2014.433","article-title":"Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis","volume":"110","author":"Eaton","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.011_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23277","article-title":"Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis","volume":"51","author":"Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib32","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/ajg.2011.272","article-title":"Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma","volume":"106","author":"Barr Fritcher","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2026.04.011_bib33","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/hep.29730","article-title":"Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis","volume":"67","author":"Ali","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.cld.2026.04.011_bib35","doi-asserted-by":"crossref","first-page":"e0442","DOI":"10.1097\/HC9.0000000000000442","article-title":"Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis","volume":"8","author":"Tan","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cld.2026.04.011_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/liv.15286","article-title":"Impact on follow-up strategies in patients with primary sclerosing cholangitis","volume":"43","author":"Bergquist","year":"2023","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.cld.2026.04.011_bib37","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SLA.0000000000006433","article-title":"Transplantation Wwithin 6 Mmonths of registration does not enhance survival for patients with perihilar cholangiocarcinoma","volume":"283","author":"Nasser-Ghodsi","year":"2026","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2026.04.011_bib38","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/SLA.0000000000006815","article-title":"Development of the perihilar cholangiocarcinoma risk estimation of tumor recurrence after transplant (PRETREAT) score","volume":"282","author":"Li","year":"2025","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2026.04.011_bib39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2022.11.011","article-title":"Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis","volume":"78","author":"Villard","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.04.011_bib40","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1136\/gutjnl-2018-316801","article-title":"Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis","volume":"68","author":"Rupp","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.cld.2026.04.011_bib41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical Practice Guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.04.011_bib42","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2147\/CMAR.S158155","article-title":"Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis","volume":"10","author":"Sun","year":"2018","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.cld.2026.04.011_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jhep.2023.02.027","article-title":"Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma","volume":"79","author":"Lapitz","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.04.011_bib44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/hep.32125","article-title":"Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile","volume":"75","author":"Vedeld","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib45","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinre.2018.08.013","article-title":"Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis","volume":"43","author":"Wannhoff","year":"2019","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.011_bib46","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/HEP.0000000000000970","article-title":"Utility of methylated DNA markers for the diagnosis of malignant biliary strictures","volume":"81","author":"Cooley","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejca.2022.10.015","article-title":"Methylation biomarkers for early cancer detection and diagnosis: current and future perspectives","volume":"178","author":"Ibrahim","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cld.2026.04.011_bib48","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1136\/gutjnl-2022-327099","article-title":"Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions","volume":"71","author":"Macias","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cld.2026.04.011_bib49","article-title":"Application of AI on cholangiocarcinoma","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.011_bib50","first-page":"47","article-title":"Multicenter validation of a cholangioscopy artificial intelligence system for the evaluation of biliary tract disease","volume":"58","author":"Marya","year":"2026","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.cld.2026.04.011_bib51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/HEP.0000000000001314","article-title":"Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"83","author":"Singh","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2026.04.011_bib52","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.hpb.2021.04.011","article-title":"Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study","volume":"23","author":"Jansson","year":"2021","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.cld.2026.04.011_bib53","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/SLA.0000000000005641","article-title":"Liver transplantation as a new standard of care in patients with perihilar cholangiocarcinoma? Results from an international benchmark Study","volume":"276","author":"Breuer","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.cld.2026.04.011_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0889-8553(21)00068-6","article-title":"Liver transplantation for malignant disease","volume":"22","author":"Gores","year":"1993","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cld.2026.04.011_bib55","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cld.2026.04.011_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.gastro.2012.04.008","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","volume":"143","author":"Darwish","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2026.04.011_bib57","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1477-2574.2011.00298.x","article-title":"Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination","volume":"13","author":"Heimbach","year":"2011","journal-title":"HPB"},{"key":"10.1016\/j.cld.2026.04.011_bib58","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and Cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.cld.2026.04.011_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cld.2026.04.011_bib60","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cld.2026.04.011_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5306\/wjco.v15.i3.381","article-title":"Current interventional options for palliative care for patients with advanced-stage cholangiocarcinoma","volume":"15","author":"Makki","year":"2024","journal-title":"World J Clin Oncol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:35:07Z","timestamp":1784763307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326126000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1089326126000450"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perihilar Cholangiocarcinoma in Primary Sclerosing Cholangitis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}